Interventional Cardiology Device Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Coronary Stents Coronary Balloon Catheters Balloon-Inflation Devices, and 12 more

List of Tables

The U.S. interventional cardiology device market was valued at nearly $4.4 billion in 2024. The market is projected to exceed $5.6 billion over the forecast period.

This report sizes and analyzes all core product categories used in percutaneous coronary intervention and related diagnostic workups, including coronary stents, coronary balloon catheters, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices (EPDs), coronary atherectomy and intravascular lithotripsy (IVL) devices, coronary thrombectomy, coronary chronic total occlusion (CTO) systems, introducer sheaths, coronary vascular closure devices (VCDs), diagnostic coronary catheters and guidewires, coronary intravascular ultrasound (IVUS), coronary optical coherence tomography (OCT), and hemostasis valves.

Quantitative coverage includes unit sales, average selling prices, market values, growth rates, company shares, and procedure numbers.

Qualitative coverage includes market drivers and limiters, mergers and acquisitions, portfolio updates, and practical technology trends across hospitals and cath labs.

Market Overview

Interventional cardiology in the United States continues to evolve toward data-guided, image-rich, and workflow-efficient procedures. PCI volumes are expected to rise at a low single-digit rate, but device demand is shaped more by product mix than by raw volume alone.

Physicians use IVUS and OCT to size vessels, characterize plaque, and optimize stent expansion. This imaging-first approach influences selection of PTCA and specialty balloons, drug-eluting stents, and lesion preparation tools including atherectomy and IVL for calcified disease. At the same time, facilities face staffing constraints, price pressure, and contract consolidation.

These forces drive interest in bundled contracts, standardized trays, radial access, and closure devices that shorten recovery and turn rooms faster.

Over the forecast period, imaging will be more deeply integrated into planning and decision making, while stent and balloon platforms will continue to improve deliverability, profiles, and coating technologies to serve a broader range of lesions with predictable outcomes.

Market Drivers

New technological developments. Adoption of advanced cardiovascular imaging, including CT, MRI, IVUS, and OCT, improves lesion detection and procedural planning. Next-generation drug-eluting stents with refined construction and thinner drug coatings are expected to enhance effectiveness and broaden treatable lesion types.

High rate of research and development. A growing patient population attracts more participants across segments. Competition accelerates innovation in guidewires, micro-catheters, balloons, atherectomy, IVL, and closure devices, leading to faster and less invasive procedures with more consistent results.

Rising rates of diabetes. In 2021, about 11 percent of the U.S. population had diabetes. This disease burden raises the prevalence of coronary artery disease and supports steady PCI demand, particularly in complex lesions associated with diffuse atherosclerosis and calcification.

PCI procedure volume. PCI is projected to grow at a low single-digit rate. Even modest procedural expansion increases demand for stents, balloon catheters, interventional catheters, guidewires, and associated equipment used in each case.

Imaging-led optimization. Facilities invest in IVUS consoles, OCT platforms, and imaging catheters to reduce geographic miss, optimize stent expansion, and document results for quality programs and payers.

Radial access and recovery. Wider use of radial access supports patient comfort and shorter stays. This favors micro-introducers, radial-specific sheaths, and closure devices tailored to rapid hemostasis and early ambulation.

Lesion preparation tools. Complex calcified lesions drive use of atherectomy and IVL to improve deliverability and ensure full stent expansion, which reduces restenosis risk and repeat procedures.

Market Limiters

External market shortages. Skilled labor shortages affect both suppliers and providers. Production delays, longer service cycles, and staffing gaps in cath labs slow throughput and weight capital planning. These pressures also push the market toward automation and streamlined product choices.

Bundling and price pressure. Large competitors use broad portfolios to negotiate system-wide contracts covering stents, balloons, guidewires, catheters, and VCDs. Bundling simplifies procurement but compresses ASPs and challenges smaller manufacturers. As consolidation continues, steady price declines are expected in many categories.

Alternative treatment methods for CAD. Beyond PCI, patients and clinicians use rehab programs, medical therapy optimization, and personal self-management. Complementary and alternative approaches, self-testing, and drug advances can delay or substitute for interventions in some cases, dampening procedural growth.

Capital diligence for imaging. OCT and IVUS require upfront console investment and ongoing disposable costs. Some centers phase adoption while they evaluate utilization and reimbursement patterns.

Supply chain and regulatory friction. Portfolio refreshes and compliance steps can lengthen launch timelines and complicate inventory.

Market Coverage and Data Scope

Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, average selling prices, and procedure numbers.

Qualitative coverage. Growth drivers and limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where applicable, disruptive technologies, and disease overviews that influence PCI care pathways.

Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2024.

Data sources. Primary interviews with industry leaders and physicians, government physician and procedure data, regulatory databases, hospital private data, import and export data, and the iData Research internal database.

Method note. Revenue is modeled from units multiplied by ASP and validated against PCI volumes, imaging adoption, access approach mix, and facility purchasing patterns across hospitals and integrated delivery networks.

Markets Covered and Segmentation

Coronary Stent Market

Device type. Bare-metal stent, drug-eluting stent, covered stent, bifurcated stent.

Single-year unit share breakdown by size. Diameter and length.

Coronary Balloon Catheter

Device type. PTCA balloon and specialty balloon.

Single-year unit share by classification. Compliant, semi-compliant, non-compliant.

Single-year unit share by indication. Pre-dilation and stent placement, post-dilation.

Balloon-Inflation Device

Interventional Coronary Catheter

Device type. Guiding catheter, extension guide catheter, micro-catheter.

Interventional Coronary Guidewire

Coronary Embolic Protection Device (EPD)

Coronary Atherectomy Device

Device type. Mechanical atherectomy, laser atherectomy, intravascular lithotripsy (IVL).

Coronary Thrombectomy

Coronary Chronic Total Occlusion (CTO) System

Device type. CTO guidewire, CTO catheter, CTO device.

Introducer Sheath

Device type. Standard introducer, micro-introducer.

By approach. Femoral, radial.

Coronary Vascular Closure Device (VCD)

Invasive VCD and non-invasive VCD.

Diagnostic Coronary Catheter and Guidewire

Device type. Diagnostic catheter, diagnostic guidewire, fractional flow reserve guidewire.

Coronary Intravascular Ultrasound (IVUS)

Device type. IVUS catheter, IVUS console.

Coronary Optical Coherence Tomography (OCT)

Device type. OCT catheter, OCT console.

Hemostasis Valve

Competitive Analysis

Boston Scientific was the leading competitor in 2024 with dominant positions in coronary stents, coronary balloon catheters, and coronary embolic protection devices. A new coronary drug-coated balloon is expected to support modest share expansion as adoption develops.

Abbott ranked second with a broad portfolio and frequent top positions across device categories. Abbott faces no direct competition in the OCT segment, which supports its standing across imaging-driven PCI strategies. The company is expected to maintain overall share.

ShockWave Medical ranked third and specializes in intravascular lithotripsy (IVL). IVL has been approved only in recent years but continues to expand quickly due to its ability to address calcified plaque in coronary vessels.

Other participants compete in selected stents, balloons, guidewires, catheters, VCDs, thrombectomy, and imaging. Competitive advantage reflects portfolio depth, radial access solutions, deliverability in tortuous anatomy, and the ability to tie imaging guidance to lesion preparation and device deployment.

Technology and Practice Trends

Imaging becomes procedural fabric. IVUS and OCT move from optional tools to routine guidance in many labs. Physicians rely on imaging to assess plaque morphology, calcification depth, and stent expansion. High-resolution CT supports pre-procedural planning in selected cases.

Calcium management. Growth in atherectomy and IVL reflects the need to treat heavily calcified lesions safely and predictably. These tools increase the likelihood of full stent expansion and durable outcomes.

Smarter balloons and stents. Specialty balloons with defined compliance and improved profiles, along with refined drug-eluting stents, help address complex anatomies and bifurcations while keeping procedure time under control.

Radial-first workflow. Facilities invest in radial introducers, micro-introducers, and closure solutions that support early ambulation and same-day discharge in appropriate patients.

Room efficiency. Staffing shortages push labs to standardize trays, streamline inflation devices, and select closure devices that reduce recovery time. Imaging-driven optimization also reduces repeat procedures and supports value-based targets.

Data and documentation. Imaging systems and consoles support case documentation for quality programs, peer review, and contracting, which strengthens the capital case for adoption.

Care Settings

Coverage includes hospitals, integrated delivery networks, and cath labs in academic and community settings. The report addresses procurement models that use direct purchase and group purchasing contracts, along with vendor-managed inventory where used.

Facility type influences access approach, imaging adoption, and preferences for bundled contracts.

Radial-first centers emphasize micro-introducers and closure products.

High-volume centers with complex case mix tend to invest earlier in IVUS and OCT and carry a wider range of atherectomy and IVL tools for calcium management.

Geography

This edition covers the United States.

Why This Report

Where is the largest and fastest growing opportunity within the U.S. interventional cardiology device market and how do stents, balloons, atherectomy, IVL, CTO systems, guidewires, catheters, EPDs, VCDs, IVUS, and OCT each contribute to value through 2031.

How does the interventional cardiology device market relate to the broader U.S. economy and hospital operations, including staffing constraints, capital planning for imaging, and purchasing strategies that favor bundles and standardization.

What forces will shape the market going forward, including growth in IVUS and OCT, refinement of drug-eluting stents, and the spread of radial access and same-day discharge pathways.

Which imaging modalities best support optimization in daily practice, and how should labs decide between IVUS and OCT based on case mix, reimbursement, and staff proficiency.

How will lesion preparation strategies evolve, and what is the right role for atherectomy versus IVL when treating severe calcification to ensure full expansion and reduce restenosis.

What mix of balloons is most effective across pre-dilation and post-dilation, and how do compliant, semi-compliant, and non-compliant profiles affect deliverability, safety, and consistency.

What is the expected balance between radial and femoral access, and how will this choice change demand for introducer sheaths, micro-introducers, closure devices, hemostasis valves, and accessory kits across hospitals and cath labs.

How will imaging choices evolve, in particular the adoption of OCT versus IVUS for lesion assessment, stent sizing, and post-deployment optimization, and what does this mean for console placements, disposable catheter pull-through, and training needs.

How will the next generation of drug-eluting stents and drug-coated balloons affect case selection and pricing, given the history of safety reviews and the emphasis on thinner struts, polymer changes, and controlled drug delivery.

What is the realistic trajectory for intravascular lithotripsy in calcified lesions, and how will IVL usage interact with atherectomy and high-pressure non-compliant balloons in complex PCI.

The U.S. interventional cardiology device market report from iData Research answers these questions with segment and setting models, company share analysis, pricing detail, and coverage that links imaging and access choices to device consumption.

Use it to size opportunities by category, plan product roadmaps, align contracting and inventory with hospital needs, and set targets for training and service that improve consistency across cath labs.

Product Code: iDATA_USIC25_MS

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

U.S. Interventional Cardiology Device Market Overview

Competitive Analysis

Market Developments

Market Trends

Procedure Segmentation

Procedure Codes Investigated

Market Segmentation

Key Report Updates

Version History

Research Methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

U.S. Interventional Cardiology Device Market Overview

3.1 Introduction
- 3.1.1 Population At Risk
3.2 Market Overview & Trend Analysis
3.3 Drivers And Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers And Acquisitions

Procedure Numbers

4.1 Introduction
4.2 Procedures
- 4.2.1 Angiography Procedures
- 4.2.2 Angioplasty/ Pci Procedures
- 4.2.3 Coronary Atherectomy Procedures
- 4.2.4 Coronary Chronic Total Occlusion Procedures
- 4.2.5 Catheterization Procedures
- 4.2.6 Coronary Intravascular Ultrasound Procedures
- 4.2.7 Coronary Optical Coherence Tomography Procedures
- 4.2.8 Fractional Flow Reserve Guidewire Procedures

Coronary Stent Market

5.1 Introduction
5.2 Market Overview
5.3 Market Analysis And Forecast
- 5.3.1 Total Coronary Stent Market
- 5.3.2 Bare-Metal Stent Market
- 5.3.3 Drug-Eluting Stent Market
- 5.3.4 Covered Stent Market
- 5.3.5 Bifurcated Stent Market
5.4 Unit Analysis
- 5.4.1 Coronary Stent Units Sold By Diameter
- 5.4.2 Coronary Stent Units Sold By Length
5.5 Drivers And Limiters
- 5.5.1 Market Drivers
- 5.5.2 Market Limiters
5.6 Competitive Market Share Analysis

Coronary Balloon Catheter Market

6.1 Introduction
6.2 Market Overview
6.3 Market Analysis And Forecast
- 6.3.1 Total Coronary Balloon Catheter Market
- 6.3.2 Ptca Balloon Market
- 6.3.3 Specialty Balloon Market
  - 6.3.3.1 Cutting Balloon Market
  - 6.3.3.2 Scoring Balloon Market
  - 6.3.3.3 Drug-Coated Balloon Market
- 6.3.4 Coronary Balloon Catheter Units By Classification
- 6.3.5 Coronary Balloon Catheter Units By Indication
6.4 Drivers And Limiters
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Balloon-Inflation Device Market

7.1 Introduction
7.2 Market Analysis And Forecast
7.3 Drivers And Limiters
- 7.3.1 Market Drivers
- 7.3.2 Market Limiters
7.4 Competitive Market Share Analysis

Interventional Coronary Catheter Market

8.1 Introduction
8.2 Market Overview
8.3 Market Analysis And Forecast
- 8.3.1 Total Interventional Coronary Catheter Market
- 8.3.2 Guiding Catheter Market
- 8.3.3 Extension Guide Catheter Market
- 8.3.4 Micro-Catheter Market
  - 8.3.4.1 Traditional Coronary Microcatheter Market
  - 8.3.4.1.1 Torqueable Traditional Coronary Microcatheter Market
  - 8.3.4.1.2 Braided Traditional Coronary Microcatheter Market
  - 8.3.4.2 Dual Lumen Specialty Coronary Microcatheter Market
8.4 Drivers And Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

Interventional Coronary Guidewire Market

9.1 Introduction
- 9.1.1 Device Construction
9.2 Market Analysis And Forecast
9.3 Drivers And Limiters
- 9.3.1 Market Drivers
- 9.3.2 Market Limiters
9.4 Competitive Market Share Analysis

Coronary Embolic Protection Device Market

10.1 Introduction
- 10.1.1 Saphenous Vein Grafts
- 10.1.2 Protection Mechanism
  - 10.1.2.1 Filter Basket
  - 10.1.2.2 Distal Balloon Occlusion
10.2 Market Analysis And Forecast
10.3 Drivers And Limiters
- 10.3.1 Market Drivers
- 10.3.2 Market Limiters
10.4 Competitive Market Share Analysis

Coronary Atherectomy Device Market

11.1 Introduction
- 11.1.1 Device Technologies
  - 11.1.1.1 Mechanical Atherectomy
  - 11.1.1.2 Laser Atherectomy
  - 11.1.1.3 Directional Coronary Atherectomy (Dca)
  - 11.1.1.4 Intravascular Lithotripsy
11.2 Market Overview
11.3 Market Analysis And Forecast
- 11.3.1 Total Coronary Atherectomy Device Market
- 11.3.2 Mechanical Atherectomy Market
- 11.3.3 Laser Atherectomy Market
- 11.3.4 Intravascular Lithotripsy Market
11.4 Drivers And Limiters
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Coronary Thrombectomy Market

12.1 Introduction
- 12.1.1 Drug-Eluting Stents And Thrombosis Treatment
12.2 Market Analysis And Forecast
12.3 Drivers And Limiters
- 12.3.1 Market Drivers
- 12.3.2 Market Limiters
12.4 Competitive Market Share Analysis

Coronary Chronic Total Occlusion System Market

13.1 Introduction
13.2 Market Overview
13.3 Market Analysis And Forecast
- 13.3.1 Total Coronary Chronic Total Occlusion System Market
- 13.3.2 Cto Guidewire Market
- 13.3.3 Cto Catheter Market
- 13.3.4 Cto Device Market
13.4 Drivers And Limiters
- 13.4.1 Market Drivers
- 13.4.2 Market Limiters
13.5 Competitive Market Share Analysis

Introducer Sheath Market

14.1 Introduction
14.2 Market Overview
14.3 Market Analysis And Forecast
- 14.3.1 Total Introducer Sheath Market
- 14.3.2 Standard Introducer Sheath Market
- 14.3.3 Micro-Introducer Sheath Market
14.4 Introducer Sheath Units By Approach
14.5 Drivers And Limiters
- 14.5.1 Market Drivers
- 14.5.2 Market Limiters
14.6 Competitive Market Share Analysis

Coronary Vascular Closure Device Market

15.1 Introduction
15.2 Market Overview
15.3 Market Analysis And Forecast
- 15.3.1 Total Coronary Vascular Closure Device Market
- 15.3.2 Invasive Vcd Market
- 15.3.3 Non-Invasive Vcd Market
  - 15.3.3.1 Topical Hemostat Market
  - 15.3.3.2 Radial Compression Band Market
  - 15.3.3.3 Femoral Compression Band Market
15.4 Drivers And Limiters
- 15.4.1 Market Drivers
- 15.4.2 Market Limiters
15.5 Competitive Market Share Analysis

Diagnostic Coronary Catheter & Guidewire Market

16.1 Introduction
16.2 Market Overview
16.3 Market Analysis And Forecast
- 16.3.1 Total Diagnostic Coronary Catheter & Guidewire Market
- 16.3.2 Diagnostic Catheter Market
- 16.3.3 Diagnostic Guidewire Market
- 16.3.4 Fractional Flow Reserve Guidewire Market
16.4 Drivers And Limiters
- 16.4.1 Market Drivers
- 16.4.2 Market Limiters
16.5 Competitive Market Share Analysis

Coronary Intravascular Ultrasound Market

17.1 Introduction
- 17.1.1 Pre-Stenting Applications
- 17.1.2 Post-Stenting Applications
- 17.1.3 Ivus Penetration
17.2 Market Overview
17.3 Market Analysis And Forecast
- 17.3.1 Ivus Catheter Market
- 17.3.2 Ivus Console Market
17.4 Drivers And Limiters
- 17.4.1 Market Drivers
- 17.4.2 Market Limiters
17.5 Competitive Market Share Analysis

Coronary Optical Coherency Tomography Market

18.1 Introduction
18.2 Market Overview
18.3 Market Analysis And Forecast
- 18.3.1 Oct Catheter Market
- 18.3.2 Oct Console Market
18.4 Drivers And Limiters
- 18.4.1 Market Drivers
- 18.4.2 Market Limiters
18.5 Competitive Market Share Analysis

Hemostasis Valve Market

19.1 Introduction
19.2 Market Analysis And Forecast
19.3 Drivers And Limiters
- 19.3.1 Market Drivers
- 19.3.2 Market Limiters
19.4 Competitive Market Share Analysis

Abbreviations

Product Code: iDATA_USIC25_MS

LIST OF CHARTS

Chart 1-1: Interventional Cardiology Device Market by Segment, U.S., 2024 - 2031. 2
Chart 1-2: Interventional Cardiology Device Market Overview, U.S., 2024 & 2031. 2
Chart 3-1: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031. 42
Chart 3-2: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024. 53
Chart 4-1: Interventional Cardiology Procedures by Segment, U.S., 2021 - 2031. 59
Chart 5-1: Coronary Stent Market by Segment, U.S., 2021 - 2031. 78
Chart 5-2: Leading Competitors, Coronary Stent Market, U.S., 2024. 91
Chart 6-1: Coronary Balloon Catheter Market by Segment, U.S., 2021 - 2031. 95
Chart 6-2: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2024. 110
Chart 7-1: Balloon-Inflation Device Market, U.S., 2021 - 2031. 113
Chart 7-2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2024. 119
Chart 8-1: Interventional Coronary Catheter Market by Segment, U.S., 2021 - 2031. 122
Chart 8-2: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2024. 138
Chart 9-1: Interventional Coronary Guidewire Market, U.S., 2021 - 2031. 141
Chart 9-2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2024. 147
Chart 10-1: Coronary Embolic Protection Device Market, U.S., 2021 - 2031. 151
Chart 10-2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2024. 156
Chart 11-1: Coronary Atherectomy Device Market by Segment, U.S., 2021 - 2031. 160
Chart 11-2: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2024. 169
Chart 12-1: Coronary Thrombectomy Market, U.S., 2021 - 2031. 173
Chart 12-2: Leading Competitors, Coronary Thrombectomy Market, U.S., 2024. 178
Chart 13-1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2021 - 2031. 182
Chart 13-2: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2024. 191
Chart 14-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031. 194
Chart 14-2: Leading Competitors, Introducer Sheath Market, U.S., 2024. 205
Chart 15-1: Coronary Vascular Closure Device Market by Segment, U.S., 2021 - 2031. 209
Chart 15-2: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2024. 223
Chart 16-1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2021 - 2031. 226
Chart 16-2: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2024. 236
Chart 17-1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2021 - 2031. 240
Chart 17-2: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2024. 248
Chart 18-1: Coronary Optical Coherency Tomography Market by Segment, U.S., 2021 - 2031. 252
Chart 18-2: Leading Competitors, Coronary Optical Coherency Tomography Market, U.S., 2024. 260
Chart 19-1: Hemostasis Valve Market, U.S., 2021 - 2031. 263
Chart 19-2: Leading Competitors, Hemostasis Valve Market, U.S., 2024 268

LIST OF FIGURES

Figure 1-1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (1 of 3). 3
Figure 1-2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (2 of 3). 4
Figure 1-3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2024 (3 of 3). 4
Figure 1-4: Companies Researched in This Report. 5
Figure 1-5: Recent Events in the Interventional Cardiology Device Market, U.S., 2021 - 2025 (1 of 2). 7
Figure 1-6: Recent Events in the Interventional Cardiology Device Market, U.S., 2021 - 2025 (2 of 2). 8
Figure 1-7: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (1 of 3). 9
Figure 1-8: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (2 of 3). 10
Figure 1-9: Factors Impacting the Interventional Cardiology Device Market by Segment, U.S. (3 of 3). 11
Figure 1-10: Interventional Cardiology Device Procedure Segmentation (1 of 2). 12
Figure 1-11: Interventional Cardiology Device Procedure Segmentation (2 of 2). 13
Figure 1-12: Procedure Codes Investigated. 14
Figure 1-13: Interventional Cardiology Device Market Segmentation (1 of 3). 15
Figure 1-14: Interventional Cardiology Device Market Segmentation (2 of 3). 16
Figure 1-15: Interventional Cardiology Device Market Segmentation (3 of 3). 17
Figure 1-16: Key Report Updates. 18
Figure 1-17: Version History. 19
Figure 3-1: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (1 of 3). 39
Figure 3-2: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (2 of 3). 40
Figure 3-3: Interventional Cardiology Device Market by Segment, U.S., 2021 - 2031 (US$M) (3 of 3). 41
Figure 3-4: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (1 of 3). 50
Figure 3-5: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (2 of 3). 51
Figure 3-6: Leading Competitors, Interventional Cardiology Device Market, U.S., 2024 (3 of 3). 52
Figure 4-1: Procedure Codes Investigated, U.S., 2024. 56
Figure 4-2: Interventional Cardiology Device Procedures by Segment, U.S., 2021 - 2031 (1 of 2). 57
Figure 4-3: Interventional Cardiology Device Procedures by Segment, U.S., 2021 - 2031 (2 of 2). 58
Figure 4-4: Angiography Procedures by Devices Used, U.S., 2021 - 2031. 60
Figure 4-5: Angiography Procedures by Approach, U.S., 2021 - 2031. 61
Figure 4-6: Angiography Procedures by Setting, U.S., 2021 - 2031. 61
Figure 4-7: Angioplasty Procedures by Approach, U.S., 2021 - 2031. 62
Figure 4-8: Angioplasty Procedures by Modality, U.S., 2021 - 2031. 63
Figure 4-9: Angioplasty Procedures by Setting, U.S., 2021 - 2031. 63
Figure 4-10: Atherectomy Procedures by Segment, U.S., 2021 - 2031. 65
Figure 4-11: Atherectomy Procedures by Setting, U.S., 2021 - 2031. 66
Figure 4-12: CTO Procedures by Setting, U.S., 2021 - 2031. 68
Figure 4-13: Catheterization Procedures by Setting, U.S., 2021 - 2031. 70
Figure 4-14: IVUS Procedures by Segment, U.S., 2021 - 2031. 71
Figure 4-15: OCT Procedures by Segment, U.S., 2021 - 2031. 72
Figure 4-16: FFR Procedures by Segment, U.S., 2021 - 2031. 73
Figure 5-1: Coronary Market by Segment, U.S., 2021 - 2031 (US$M). 77
Figure 5-2: Total Coronary Stent Market, U.S., 2021 - 2031. 79
Figure 5-3: Bare-Metal Stent Market, U.S., 2021 - 2031. 80
Figure 5-4: Drug-Eluting Stent Market, U.S., 2021 - 2031. 81
Figure 5-5: Covered Stent Market, U.S., 2021 - 2031. 82
Figure 5-6: Bifurcated Stent Market, U.S., 2021 - 2031. 83
Figure 5-7: Percent of Coronary Stent Units Sold by Diameter, U.S., 2024. 84
Figure 5-8: Percent of Coronary Stent Units Sold by Diameter, U.S., 2024. 85
Figure 5-9: Leading Competitors, Coronary Stent Market, U.S., 2024. 90
Figure 6-1: Coronary Balloon Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 94
Figure 6-2: Total Coronary Balloon Catheter Market, U.S., 2021 - 2031. 96
Figure 6-3: PTCA Balloon Market, U.S., 2021 - 2031. 97
Figure 6-4: Specialty Balloon Market by Segment, U.S., 2021 - 2031 (US$M). 99
Figure 6-5: Total Specialty Balloon Catheter Market, U.S., 2021 - 2031. 99
Figure 6-6: Cutting Balloon Market, U.S., 2021 - 2031. 100
Figure 6-7: Scoring Balloon Market, U.S., 2021 - 2031. 101
Figure 6-8: Drug-Coated Balloon Market, U.S., 2021 - 2031. 102
Figure 6-9: Coronary Balloon Catheter Units by Classification, U.S., 2024. 103
Figure 6-10: Coronary Balloon Catheter Units by Classification, U.S., 2024. 104
Figure 6-11: Leading Competitors, Coronary Balloon Catheter Market, U.S., 2024. 109
Figure 7-1: Balloon-Inflation Device Market, U.S., 2021 - 2031. 112
Figure 7-2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2024. 118
Figure 8-1: Interventional Coronary Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 121
Figure 8-2: Total Interventional Coronary Catheter Market, U.S., 2021 - 2031. 123
Figure 8-3: Guiding Catheter Market, U.S., 2021 - 2031. 124
Figure 8-4: Extension Guide Catheter Market, U.S., 2021 - 2031. 125
Figure 8-5: Micro-Catheter Market by Segment, U.S., 2021 - 2031 (US$M). 126
Figure 8-6: Total Micro-Catheter Market, U.S., 2021 - 2031. 127
Figure 8-7: Traditional Coronary Microcatheter Market by Segment, U.S., 2021 - 2031 (US$M). 128
Figure 8-8: Total Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 129
Figure 8-9: Torqueable Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 130
Figure 8-10: Braided Traditional Coronary Microcatheter Market, U.S., 2021 - 2031. 131
Figure 8-11: Dual Lumen Specialty Coronary Microcatheter Market, U.S., 2021 - 2031. 132
Figure 8-12: Leading Competitors, Interventional Coronary Catheter Market, U.S., 2024. 137
Figure 9-1: Interventional Coronary Guidewire Market, U.S., 2021 - 2031. 140
Figure 9-2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2024. 146
Figure 10-1: Coronary Embolic Protection Device Market, U.S., 2021 - 2031. 150
Figure 10-2: Leading Competitors, Coronary Embolic Protection Device Market, U.S., 2024. 155
Figure 11-1: Coronary Atherectomy Device Market by Segment, U.S., 2021 - 2031 (US$M). 159
Figure 11-2: Total Coronary Atherectomy Device Market, U.S., 2021 - 2031. 161
Figure 11-3: Mechanical Atherectomy Market, U.S., 2021 - 2031. 162
Figure 11-4: Laser Atherectomy Market, U.S., 2021 - 2031. 163
Figure 11-5: Intravascular Lithotripsy Market, U.S., 2021 - 2031. 164
Figure 11-6: Leading Competitors, Coronary Atherectomy Device Market, U.S., 2024. 168
Figure 12-1: Coronary Thrombectomy Market, U.S., 2021 - 2031. 172
Figure 12-2: Leading Competitors, Coronary Thrombectomy Market, U.S., 2024. 177
Figure 13-1: Coronary Chronic Total Occlusion System Market by Segment, U.S., 2021 - 2031 (US$M). 181
Figure 13-2: Total Coronary Chronic Total Occlusion System Market, U.S., 2021 - 2031. 183
Figure 13-3: CTO Guidewire Market, U.S., 2021 - 2031. 184
Figure 13-4: CTO Catheter Market, U.S., 2021 - 2031. 185
Figure 13-5: CTO Device Market, U.S., 2021 - 2031. 186
Figure 13-6: Leading Competitors, Coronary Chronic Total Occlusion System Market, U.S., 2024. 190
Figure 14-1: Introducer Sheath Market by Segment, U.S., 2021 - 2031 (US$M). 193
Figure 14-2: Total Introducer Sheath Market, U.S., 2021 - 2031. 195
Figure 14-3: Standard Introducer Sheath Market, U.S., 2021 - 2031. 196
Figure 14-4: Micro-Introducer Sheath Market, U.S., 2021 - 2031. 197
Figure 14-5: Introducer Sheath Units, by Approach, U.S., 2021 - 2031. 198
Figure 14-6: Leading Competitors, Introducer Sheath Market, U.S., 2024. 204
Figure 15-1: Coronary Vascular Closure Device Market by Segment, U.S., 2021 - 2031 (US$M). 208
Figure 15-2: Total Coronary Vascular Closure Device Market, U.S., 2021 - 2031. 211
Figure 15-3: Invasive VCD Market, U.S., 2021 - 2031. 212
Figure 15-4: Non-Invasive VCD Market by Segment, U.S., 2021 - 2031 (US$M). 213
Figure 15-5: Total Non-Invasive VCD Market, U.S., 2021 - 2031. 214
Figure 15-6: Topical Hemostat Market, U.S., 2021 - 2031. 215
Figure 15-7: Radial Compression Band Market, U.S., 2021 - 2031. 216
Figure 15-8: Femoral Compression Band Market, U.S., 2021 - 2031. 217
Figure 15-9: Leading Competitors, Coronary Vascular Closure Device Market, U.S., 2024. 222
Figure 16-1: Diagnostic Coronary Catheter & Guidewire Market by Segment, U.S., 2021 - 2031 (US$M). 225
Figure 16-2: Total Diagnostic Coronary Catheter & Guidewire Market, U.S., 2021 - 2031. 227
Figure 16-3: Diagnostic Catheter Market, U.S., 2021 - 2031. 228
Figure 16-4: Diagnostic Guidewire Market, U.S., 2021 - 2031. 229
Figure 16-5: Fractional Flow Reserve Guidewire Market, U.S., 2021 - 2031. 230
Figure 16-6: Leading Competitors, Diagnostic Coronary Catheter & Guidewire Market, U.S., 2024. 235
Figure 17-1: Coronary Intravascular Ultrasound Market by Segment, U.S., 2021 - 2031 (US$M). 239
Figure 17-2: IVUS Catheter Market, U.S., 2021 - 2031. 242
Figure 17-3: IVUS Console Market, U.S., 2021 - 2031. 243
Figure 17-4: Leading Competitors, Coronary Intravascular Ultrasound Market, U.S., 2024. 247
Figure 18-1: Coronary Optical Coherency Tomography Market by Segment, U.S., 2021 - 2031 (US$M). 251
Figure 18-2: OCT Catheter Market, U.S., 2021 - 2031. 253
Figure 18-3: OCT Console Market, U.S., 2021 - 2031. 254
Figure 18-4: Leading Competitors, Coronary Optical Coherency Tomography Market, U.S., 2024. 259
Figure 19-1: Hemostasis Valve Market, U.S., 2021 - 2031. 262
Figure 19-2: Leading Competitors, Hemostasis Valve Market, U.S., 2024. 267